Uneek Mehra
Director of Finance/CFO chez 4D MOLECULAR THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Uneek Mehra is currently the Chief Financial & Business Officer at 4D Molecular Therapeutics, Inc. Prior to this, he held the position of Chief Financial Officer at Proteus Digital Health, Inc. and Chief Financial & Business Officer at Myovant Sciences, Inc. and Myovant Sciences Ltd.
He also served as the Chief Financial Officer & Treasurer at PACT Pharma, Inc. Mr. Mehra completed his undergraduate degree at Birla Institute of Technology & Science, his graduate degree at the University of Mumbai, and his MBA at the International Institute for Management Development.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/12/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Uneek Mehra
| Sociétés | Poste | Début |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Director of Finance/CFO | 12/09/2023 |
Anciens postes connus de Uneek Mehra
| Sociétés | Poste | Fin |
|---|---|---|
Proteus Digital Health, Inc.
 Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Director of Finance/CFO | - |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Director of Finance/CFO | - |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Director of Finance/CFO | - |
| MYOVANT SCIENCES LTD. | Director of Finance/CFO | - |
Formation de Uneek Mehra
| Birla Institute of Technology & Science | Undergraduate Degree |
| University of Mumbai | Graduate Degree |
| International Institute for Management Development | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
PACT Pharma, Inc.
PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
